Physiologically, decreased GR levels are associated with GC resistance in rheumatoid arthritis [33], [34], lupus nephritis [35], bronchial asthma [36] and sepsis [37], while increased GR levels are linked to GC sensitivity in a range of cancers. This evidence concerns the gene NR3C1 and cancer.